Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
GDRX GoodRx Holdings Inc
- Stocks
- Healthcare
- NASDAQ: GDRX
Price (delayed)
$4.9
Market cap
$1.75B
P/E Ratio
70
Dividend/share
N/A
EPS
$0.07
Enterprise value
$1.99B
GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different
Highlights
The company's EPS has surged by 75% QoQ
GoodRx Holdings's net income has surged by 74% QoQ
GoodRx Holdings's equity has decreased by 10% from the previous quarter but it has increased by 3.7% YoY
The quick ratio has decreased by 23% YoY and by 7% from the previous quarter
Key stats
What are the main financial stats of GDRX
Market
Valuations
Earnings
Shares outstanding
357.17M
Market cap
$1.75B
Enterprise value
$1.99B
Price to earnings (P/E)
70
Price to book (P/B)
2.87
Price to sales (P/S)
2.33
EV/EBIT
20.57
EV/EBITDA
11.33
EV/Sales
2.5
Revenue
$797.41M
Gross profit
$748.3M
Operating income
$81.85M
Net income
$28.45M
EBIT
$96.76M
EBITDA
$175.64M
Free cash flow
$79.11M
Per share
Balance sheet
Liquidity
EPS
$0.07
EPS diluted
$0.08
Free cash flow per share
$0.21
Book value per share
$1.71
Revenue per share
$2.1
TBVPS
$1.78
Total assets
$1.3B
Total liabilities
$640.92M
Debt
$541.19M
Equity
$654.35M
Working capital
$436.83M
Debt to equity
0.83
Current ratio
5.23
Quick ratio
4.46
Net debt/EBITDA
1.37
Margins
Efficiency
Dividend
EBITDA margin
22%
Gross margin
93.8%
Net margin
3.6%
Operating margin
10.3%
Return on assets
2.1%
Return on equity
4.1%
Return on invested capital
11.6%
Return on capital employed
8.1%
Return on sales
12.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GDRX stock price
How has the GoodRx Holdings stock price performed over time
Intraday
-3.07%
1 week
-0.61%
1 month
24.37%
1 year
-37.26%
YTD
5.38%
QTD
-1.61%
Financial performance
How have GoodRx Holdings's revenue and profit performed over time
Revenue
$797.41M
Gross profit
$748.3M
Operating income
$81.85M
Net income
$28.45M
Gross margin
93.8%
Net margin
3.6%
GoodRx Holdings's net income has surged by 74% QoQ
The net margin has soared by 71% from the previous quarter
The company's operating income rose by 24% QoQ
The operating margin has increased by 24% QoQ
Price vs fundamentals
How does GDRX's price correlate with its fundamentals
Growth
What is GoodRx Holdings's growth rate over time
Valuation
What is GoodRx Holdings stock price valuation
P/E
70
P/B
2.87
P/S
2.33
EV/EBIT
20.57
EV/EBITDA
11.33
EV/Sales
2.5
The company's EPS has surged by 75% QoQ
GDRX's P/B is 67% below its 5-year quarterly average of 8.9 and 10% below its last 4 quarters average of 3.3
GoodRx Holdings's equity has decreased by 10% from the previous quarter but it has increased by 3.7% YoY
The price to sales (P/S) is 76% lower than the 5-year quarterly average of 9.8 and 17% lower than the last 4 quarters average of 2.9
The revenue is up by 4.4% YoY
Efficiency
How efficient is GoodRx Holdings business performance
GoodRx Holdings's ROA has soared by 75% from the previous quarter
The company's return on equity has surged by 71% QoQ
The company's return on invested capital rose by 20% QoQ
The company's return on sales rose by 14% QoQ
Dividends
What is GDRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GDRX.
Financial health
How did GoodRx Holdings financials performed over time
GoodRx Holdings's total assets is 102% more than its total liabilities
The quick ratio has decreased by 23% YoY and by 7% from the previous quarter
The total liabilities has decreased by 22% YoY and by 3.4% QoQ
The debt is 17% less than the equity
GDRX's debt to equity is down by 27% year-on-year but it is up by 11% since the previous quarter
The debt is down by 24% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.